Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Authors:
Top Cited Papers
- 1 October 2016
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 388 (10054) , 1883-1892
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literatureExperimental and Therapeutic Medicine, 2012
- Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphismsAnnals of Oncology, 2009
- Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinomaOral Oncology, 2008
- Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinomaHead & Neck, 2005
- Gemcitabine and Cisplatin in Advanced Nasopharyngeal Carcinoma: A Pilot StudyCancer Investigation, 2005
- Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinomaCancer, 2004
- Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic groupCancer, 2004
- Chemotherapy with gemcitabine‐containing regimens for locally recurrent or metastatic nasopharyngeal carcinomaCancer, 2002
- Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated typeAnnals of Oncology, 2002
- Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992